Gary Hudes

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

New England Journal of Medicine · 2007 · First of 20 authors · Corresponding · 2,970 citations

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell…

Journal of Clinical Oncology · 2006 · 1,304 citations